Levaggi R., Pertile P. (2020) Authors’ Reply to Garattini and Freemantle: “Value-Based Pricing Alternatives for Personalised Drugs: Implications of Asymmetric Information and Competition”. Applied health economics and health policy, 18(3), 455-456.

Levaggi R., Pertile P. (2020) Authors’ Reply to Garattini and Freemantle: “Value-Based Pricing Alternatives for Personalised Drugs: Implications of Asymmetric Information and Competition”. Applied health…